Targeting a novel apoptotic pathway in human disease
暂无分享,去创建一个
P. Fiorina | F. D’Addio | C. Bruckmann | L. Montefusco | I. Pastore | V. Marin | Adriana Petrazzuolo | E. Assi | M. E. Lunati
[1] J. Markmann,et al. The IGFBP3/TMEM219 pathway regulates beta cell homeostasis , 2022, Nature Communications.
[2] T. Kanneganti,et al. Programming inflammatory cell death for therapy. , 2021, Pharmacology & therapeutics.
[3] J. Inadomi,et al. Screening and prevention of colorectal cancer , 2021, BMJ.
[4] O. Kepp,et al. Pharmacological inhibitors of anaplastic lymphoma kinase (ALK) induce immunogenic cell death through on-target effects , 2021, Cell Death & Disease.
[5] M. Simrén,et al. The overlap between irritable bowel syndrome and organic gastrointestinal diseases. , 2020, The lancet. Gastroenterology & hepatology.
[6] M. Dozmorov,et al. IGFBP-3/IGFBP-3 Receptor System as an Anti-Tumor and Anti-Metastatic Signaling in Cancer , 2020, Cells.
[7] M. Emami,et al. The insulin‐like growth factor binding protein‐3 and its death receptor in pancreatic ductal adenocarcinoma poor prognosis , 2019, Journal of cellular physiology.
[8] Adel M Nour,et al. Blocking transmembrane219 protein signaling inhibits autophagy and restores normal cell death , 2019, PloS one.
[9] Y. Modis,et al. IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses , 2016, Nature Communications.
[10] P. Fiorina,et al. Type 1 Diabetes and Dysfunctional Intestinal Homeostasis , 2016, Trends in Endocrinology & Metabolism.
[11] Eduard Batlle,et al. Circulating IGF-I and IGFBP3 Levels Control Human Colonic Stem Cell Function and Are Disrupted in Diabetic Enteropathy. , 2015, Cell stem cell.
[12] Dae-Yeol Lee,et al. Identification of a Novel Cell Death Receptor Mediating IGFBP-3-induced Anti-tumor Effects in Breast and Prostate Cancer* , 2010, The Journal of Biological Chemistry.
[13] R. Baxter. Signalling pathways involved in antiproliferative effects of IGFBP-3: a review , 2001, Molecular pathology : MP.
[14] Z. Gucev,et al. Antiproliferative actions of insulin-like growth factor binding protein (IGFBP)-3 in human breast cancer cells. , 1995, Progress in growth factor research.